$ACT

Genworth Holdings, Inc. sold $24.0M of ACT

Genworth Holdings, Inc. sold 523,226 shares of Enact Holdings, Inc. (ACT) at $45.92 ($24.03M total) on 2026-07-31.

Original reporting
SEC EDGAR · Genworth Holdings, Inc.
Published Aug 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:16 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACT
Neutral
medium confidence
Mentioned
$ACT
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACTNeutralLow
01

Why it matters

A 10% owner sold about $24.0M of ACT shares at a stated price, which may influence short-term sentiment but does not, by itself, change fundamentals.

02

Market read

Traders may monitor ACT for follow-through in sentiment, but the filing alone is unlikely to drive a durable repricing without accompanying company news.

03

What to watch

The article does not state whether the insider’s remaining stake is still large, nor does it provide context on prior sales cadence or any concurrent company-specific news.

Relevance 7/10Novelty 4/10Timing: Filed 2026-08-03, covering a sale dated 2026-07-31.

Background

This is an SEC Form 4 insider transaction disclosure (open-market sale) reported via SEC EDGAR.

Company-level read

Ticker impact

$ACTNeutralMedium confidence
Context

Genworth Holdings reported an open-market sale by a 10% owner of ACT: 523,226 shares sold at $45.9192 on 2026-07-31 for about $24.0M.

Expected impact

Near-term impact likely limited; any effect is more sentiment-driven than thesis-changing.

Evidence & confidence

Form 4 insider sales are common and the filing notes no 10b5-1 plan, but the article provides no new company fundamentals, guidance, or regulatory/legal developments.

Market effects

No sector-level implications are disclosed; this is a single-issuer insider transaction.

None indicated.

None indicated.

Counterpoint

Large insider sales can reflect diversification or liquidity needs rather than bearish expectations, especially when not tied to a new negative catalyst in the filing.

Key entities

  • ACT

    Enact Holdings, Inc., the issuer of the reported insider sale.

  • Genworth Holdings, Inc.

    Reporter of the Form 4 transaction for the 10% owner.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACTMedAI 8/10

Enact (ACT) Q2 2026 Earnings Call Transcript

Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.